Toyonaka, Japan

Yoshihiro Sugihara


Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 40(Granted Patents)


Location History:

  • Osaka, JP (1992)
  • Toyonaka, JP (1991 - 1994)
  • Tsukuba, JP (1996)
  • Ikoma, JP (2003 - 2008)

Company Filing History:


Years Active: 1991-2008

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Yoshihiro Sugihara

Introduction

Yoshihiro Sugihara is a prominent inventor based in Toyonaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target HIV. With a total of 7 patents to his name, Sugihara's work has the potential to impact the treatment of infectious diseases.

Latest Patents

Among his latest patents are cyclic amine compounds that serve as CCR5 antagonists. These compounds are designed to have potent CCR5 antagonistic activity, making them advantageous for the treatment or prevention of various HIV infections in humans, including AIDS. The detailed chemical formulations of these compounds highlight their complexity and potential efficacy in medical applications.

Career Highlights

Throughout his career, Sugihara has worked with notable companies such as Takeda Chemical Industries, Inc. and Hitachi, Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Sugihara has collaborated with esteemed colleagues, including Koichi Matsumura and Teruo Kitamura. These partnerships have fostered an environment of innovation and have led to advancements in their respective fields.

Conclusion

Yoshihiro Sugihara's contributions to medicinal chemistry and his innovative patents position him as a key figure in the fight against infectious diseases. His work continues to inspire future research and development in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…